Novotech, Biotech’s Partner At Every Phase

Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech and small to mid-sized pharma companies to accelerate the development of advanced and novel therapeutics at every phase.

Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the Global Biotech CRO Company of the Year Award 2024,  CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award 2023.  The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.

Headquartered in Sydney, Australia. Phone: +61 2 8569 1400 with a regional office in California 400 Oyster Point Boulevard, Suite 401, South San Francisco, CA 94080

Contact

Barry Murphy Chief Commercial Officer
Aditya Kotta Sr. Director of Business Development, US
novotech-cro.com/
400 Oyster Point Boulevard Suite 401 South San Francisco, CA 94080 United States